2020
DOI: 10.7554/elife.60742
|View full text |Cite
|
Sign up to set email alerts
|

Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation

Abstract: Spinocerebellar ataxia type 3 (SCA3) belongs to the family of polyglutamine neurodegenerations. Each disorder stems from the abnormal lengthening of a glutamine repeat in a different protein. Although caused by a similar mutation, polyglutamine disorders are distinct, implicating non-polyglutamine regions of disease proteins as regulators of pathogenesis. SCA3 is caused by polyglutamine expansion in ataxin-3. To determine the role of ataxin-3’s non-polyglutamine domains in disease, we utilized a new, allelic s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
53
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 21 publications
(54 citation statements)
references
References 92 publications
1
53
0
Order By: Relevance
“…Mutating the pathogenic ataxin-3 VBM improved fly motility and longevity compared to counterparts expressing pathogenic ataxin-3 Q80 with an intact VBM ( Ristic et al, 2018 ). Biochemically, mutating ataxin-3’s VBM or reducing the levels of VCP through RNA-interference did not reduce SCA3 protein levels, but decreased pathogenic ataxin-3 aggregation ( Johnson et al, 2020 ; Ristic et al, 2018 ) – a critical observation given that, in our assays with pathogenic ataxin-3, its aggregation precedes toxicity ( Johnson et al, 2019 ; Johnson et al, 2020 ; Ristic et al, 2018 ; Sutton et al, 2017 ). These and other findings led us to conclude that pathogenic ataxin-3 with a mutated VBM is less aggregation-prone and less toxic.…”
Section: Introductionmentioning
confidence: 73%
See 3 more Smart Citations
“…Mutating the pathogenic ataxin-3 VBM improved fly motility and longevity compared to counterparts expressing pathogenic ataxin-3 Q80 with an intact VBM ( Ristic et al, 2018 ). Biochemically, mutating ataxin-3’s VBM or reducing the levels of VCP through RNA-interference did not reduce SCA3 protein levels, but decreased pathogenic ataxin-3 aggregation ( Johnson et al, 2020 ; Ristic et al, 2018 ) – a critical observation given that, in our assays with pathogenic ataxin-3, its aggregation precedes toxicity ( Johnson et al, 2019 ; Johnson et al, 2020 ; Ristic et al, 2018 ; Sutton et al, 2017 ). These and other findings led us to conclude that pathogenic ataxin-3 with a mutated VBM is less aggregation-prone and less toxic.…”
Section: Introductionmentioning
confidence: 73%
“…Human ataxin-3 cDNAs were based on sequences from previous publications and include either 77 or 80Q ( Berke et al, 2005 ; Blount et al, 2012 ; Harris et al, 2010 ; Johnson et al, 2019 ; Johnson et al, 2020 ; Nicastro et al, 2009 ; Nicastro et al, 2010 ; Ristic et al, 2018 ; Sutton et al, 2017 ; Todi et al, 2009 ; Tsou et al, 2015b ; Winborn et al, 2008 ). We used the company Genscript ( genscript.com ) to synthesize the VCP N-terminus cDNA as well as full-length fly VCP.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Furthermore, AT-3 UIMs are involved in multivalent binding to the Ubl domain of the E3 ubiquitin ligase parkin ( Bai et al, 2013 ; Aguirre et al, 2018 ). It has also been suggested that the three UIMs of AT-3 interact with the heat shock protein Hsc70-4 in Drosophila melanogaster ( Johnson et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%